At a glance
- Originator Nippon Kayaku
- Class Antineoplastics
- Mechanism of Action T lymphocyte inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Immunological disorders; Ovarian cancer
Most Recent Events
- 08 Jun 2001 No-Development-Reported for Immunological disorders in Japan (unspecified route)
- 08 Jun 2001 No-Development-Reported for Ovarian cancer in Japan (unspecified route)
- 16 Apr 1998 Preclinical development for Immunological disorders in Japan (unspecified route)